{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T18:57:01Z","timestamp":1775933821449,"version":"3.50.1"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.1001\/jamaoncol.2019.6722","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T16:30:56Z","timestamp":1582821056000},"page":"696","source":"Crossref","is-referenced-by-count":30,"title":["Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant"],"prefix":"10.1001","volume":"6","author":[{"given":"Pamela","family":"Stratton","sequence":"first","affiliation":[{"name":"Office of the Clinical Director, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland"},{"name":"Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoo","family":"Battiwalla","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland"},{"name":"Sarah Cannon Research Institute, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Tian","sequence":"additional","affiliation":[{"name":"Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Abdelazim","sequence":"additional","affiliation":[{"name":"Clinical Center, National Institutes of Health, Bethesda, Maryland"},{"name":"Riverside Regional Medical Center, Newport News, Virginia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Baird","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. John","family":"Barrett","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland"},{"name":"GW Cancer Center, The George Washington University Hospital, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline R.","family":"Cantilena","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland"},{"name":"University of Kansas School of Medicine, Kansas City"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard W.","family":"Childs","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"DeJesus","sequence":"additional","affiliation":[{"name":"Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Fitzhugh","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Fowler","sequence":"additional","affiliation":[{"name":"Experimental Transplant and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"},{"name":"Rapa Therapeutics, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Gea-Banacloche","sequence":"additional","affiliation":[{"name":"Experimental Transplant and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"},{"name":"Infectious Diseases Division, Mayo Clinic Arizona, Phoenix, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald E.","family":"Gress","sequence":"additional","affiliation":[{"name":"Experimental Transplant and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Hickstein","sequence":"additional","affiliation":[{"name":"Experimental Transplant and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sawa","family":"Ito","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland"},{"name":"Hematopoietic Stem Cell Transplant and Cell Therapy, Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Troy J.","family":"Kemp","sequence":"additional","affiliation":[{"name":"HPV Immunology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izabella","family":"Khachikyan","sequence":"additional","affiliation":[{"name":"Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland"},{"name":"Office of New Drugs, Center for Drug Evaluation and Research, Division of Anesthesia, Analgesia, and Addiction Products, US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa A.","family":"Merideth","sequence":"additional","affiliation":[{"name":"Office of the Clinical Director, National Human Genome Research Institute, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven Z.","family":"Pavletic","sequence":"additional","affiliation":[{"name":"Experimental Transplant and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"Quint","sequence":"additional","affiliation":[{"name":"DDL Diagnostic Laboratory, Rijswijk, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[{"name":"Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Scrivani","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland"},{"name":"University of Virginia School of Medicine, Charlottesville"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Shanis","sequence":"additional","affiliation":[{"name":"Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland"},{"name":"Rittenhouse Women's Wellness Center, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aarthi G.","family":"Shenoy","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland"},{"name":"Department of Hematology\/Oncology, MedStar Washington Hospital Center, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Struijk","sequence":"additional","affiliation":[{"name":"DDL Diagnostic Laboratory, Rijswijk, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Tisdale","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Wagner","sequence":"additional","affiliation":[{"name":"Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc, Frederick, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten M.","family":"Williams","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland"},{"name":"Children\u2019s Research Institute, Children\u2019s National, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Yu","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren V.","family":"Wood","sequence":"additional","affiliation":[{"name":"Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland"},{"name":"PDS Biotechnology, Berkeley Heights, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ligia A.","family":"Pinto","sequence":"additional","affiliation":[{"name":"HPV Immunology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"7413","key":"coi190115r1","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/488S2a","article-title":"HPV: the global burden.","volume":"488","author":"Crow","year":"2012","journal-title":"Nature"},{"key":"coi190115r2","doi-asserted-by":"publisher","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases.","volume":"30","author":"Forman","year":"2012","journal-title":"Vaccine"},{"issue":"7","key":"coi190115r3","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1002\/cncr.v113:7+","article-title":"Human papillomavirus infection and the primary and secondary prevention of cervical cancer.","volume":"113","author":"Lowy","year":"2008","journal-title":"Cancer"},{"issue":"12","key":"coi190115r4","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1002\/cam4.538","article-title":"Early-life exposures to infectious agents and later cancer development.","volume":"4","author":"Vedham","year":"2015","journal-title":"Cancer Med"},{"issue":"5","key":"coi190115r5","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.bbmt.2011.09.012","article-title":"A clinical study of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation.","volume":"18","author":"Wang","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"coi190115r6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/bmt.2017.210","article-title":"Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study.","volume":"53","author":"Shanis","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"coi190115r7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.6004\/jnccn.2018.7005","article-title":"Secondary neoplasms of the female lower genital tract after hematopoietic cell transplantation.","volume":"16","author":"Chang","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"coi190115r8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11864-018-0528-y","article-title":"Second malignancies after hematopoietic stem cell transplantation.","volume":"19","author":"Danylesko","year":"2018","journal-title":"Curr Treat Options Oncol"},{"issue":"4","key":"coi190115r9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/14760584.2018.1449649","article-title":"Vaccination post-allogeneic hematopoietic stem cell transplantation: what is feasible?","volume":"17","author":"Conrad","year":"2018","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"coi190115r10","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.bbmt.2011.12.519","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.","volume":"18","author":"Majhail","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"coi190115r11","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.bbmt.2016.10.001","article-title":"National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: the Immune Dysregulation and Pathobiology Working Group Report.","volume":"23","author":"Gea-Banacloche","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"coi190115r12","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.ygyno.2009.09.021","article-title":"HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives.","volume":"115","author":"Castellsagu\u00e9","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"7","key":"coi190115r13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrclinonc.2013.84","article-title":"Clinical trials of human papillomavirus vaccines and beyond.","volume":"10","author":"Lehtinen","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"coi190115r14","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.4161\/hv.36121","article-title":"Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine and HPV-6\/11\/16\/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a phase III randomized trial.","volume":"10","author":"Einstein","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"49","key":"coi190115r15","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.15585\/mmwr.mm6549a5","article-title":"Use of a 2-dose schedule for human papillomavirus vaccination\u2014updated recommendations of the Advisory Committee on Immunization Practices.","volume":"65","author":"Meites","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"coi190115r16","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. diagnosis and staging working group report.","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"16","key":"coi190115r17","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology.","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"issue":"3","key":"coi190115r18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/LGT.0b013e31824bc178","article-title":"New guidelines on cervical cancer screening: more than just the end of annual Pap testing.","volume":"16","author":"Massad","year":"2012","journal-title":"J Low Genit Tract Dis"},{"issue":"9","key":"coi190115r19","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1200\/JCO.1998.16.9.3148","article-title":"Prevalence and predictors of sexual dysfunction in long-term survivors of marrow transplantation.","volume":"16","author":"Syrjala","year":"1998","journal-title":"J Clin Oncol"},{"issue":"29-30","key":"coi190115r20","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.1016\/j.vaccine.2008.04.074","article-title":"Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women.","volume":"26","author":"Kemp","year":"2008","journal-title":"Vaccine"},{"issue":"12","key":"coi190115r21","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.4161\/hv.34408","article-title":"Comparison of adaptive and innate immune responses induced by licensed vaccines for human papillomavirus.","volume":"10","author":"Herrin","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"coi190115r22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068329","article-title":"Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica.","volume":"8","author":"Herrero","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"coi190115r23","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1128\/JCM.37.8.2508-2517.1999","article-title":"Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus.","volume":"37","author":"Kleter","year":"1999","journal-title":"J Clin Microbiol"},{"issue":"6","key":"coi190115r24","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/S0002-9440(10)65688-X","article-title":"Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses.","volume":"153","author":"Kleter","year":"1998","journal-title":"Am J Pathol"},{"issue":"5","key":"coi190115r25","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01794-18","article-title":"Development of the TypeSeq assay for detection of 51 HPV genotypes by next generation sequencing.","volume":"57","author":"Wagner","year":"2019","journal-title":"J Clin Microbiol"},{"key":"coi190115r26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pvr.2017.03.002","article-title":"Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine\u2014a combined analysis of five phase III clinical trials.","volume":"3","author":"Petersen","year":"2017","journal-title":"Papillomavirus Res"},{"issue":"47","key":"coi190115r27","doi-asserted-by":"publisher","first-page":"6303","DOI":"10.1016\/j.vaccine.2014.08.071","article-title":"Immunogenicity of bivalent HPV vaccine among partially vaccinated young adolescent girls in Uganda.","volume":"32","author":"LaMontagne","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"coi190115r28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/08923973.2017.1392562","article-title":"Infectious diseases and immunological markers associated with patients with non-Hodgkin lymphoma treated with rituximab.","volume":"40","author":"de Souza","year":"2018","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"12","key":"coi190115r29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1172\/jci.insight.93222","article-title":"Robust memory responses against influenza vaccination in pemphigus patients previously treated with rituximab.","volume":"2","author":"Cho","year":"2017","journal-title":"JCI Insight"},{"issue":"5","key":"coi190115r30","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00467-017-3868-0","article-title":"Vaccination titres pre- and post-transplant in paediatric renal transplant recipients and the impact of immunosuppressive therapy.","volume":"33","author":"H\u00f6cker","year":"2018","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"coi190115r31","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1177\/0091270007305297","article-title":"Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response.","volume":"47","author":"Breedveld","year":"2007","journal-title":"J Clin Pharmacol"},{"issue":"32 Pt A","key":"coi190115r32","doi-asserted-by":"publisher","first-page":"4768","DOI":"10.1016\/j.vaccine.2017.12.079","article-title":"Explanations for the high potency of HPV prophylactic vaccines.","volume":"36","author":"Schiller","year":"2018","journal-title":"Vaccine"},{"issue":"6","key":"coi190115r33","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1097\/AOG.0000000000002052","article-title":"Committee opinion No. 704: human papillomavirus vaccination.","volume":"129","author":"Immunization Expert Work Group, Committee on Adolescent Health Care","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"7","key":"coi190115r34","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1001\/jama.298.7.805","article-title":"HPV vaccines prophylactic, not therapeutic.","volume":"298","author":"Markowitz","year":"2007","journal-title":"JAMA"},{"issue":"8","key":"coi190115r35","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.","volume":"372","author":"Joura","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"coi190115r37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nrclinonc.2015.146","article-title":"HPV-FASTER: broadening the scope for prevention of HPV-related cancer.","volume":"13","author":"Bosch","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"coi190115r36","unstructured":"US Food & Drug Administration. FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-expanded-use-gardasil-9-include-individuals-27-through-45-years-old. Accessed January 3, 2019."}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2761958\/jamaoncology_stratton_2020_oi_190115.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T03:31:01Z","timestamp":1589513461000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2761958"}},"subtitle":["A Nonrandomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2019.6722","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}